Supreme Court Report

Supreme Court of the United States · Official docket →

Afoluso Adesanya, et vir v. Novartis Pharmaceuticals Corp.

Paid petition · United States Court of Appeals for the Third Circuit, No. 17-2368 · judgment October 11, 2018

Certiorari denied · April 15, 2019
Pre-decision estimate: 0% cert probability

Before the decision, well below the 4.1% base rate, with no standout signals pointing toward a grant.

Question presented

Whether the 3rd Circuit Appeals Court erred in upholding the decision of Federal District Court to dismiss Petitioner One employment discrimination Lawsuit as a sanction, without any prior court finding or warning of discovery violation or disobedience to a discovery order against petitioner. Whether the 3rd Circuit Appeals Court erred in upholding the Federal District Court's engagement in unlawful Ex-parte communications with respondent, in violation of the Code of Conduct for United States Judges, to the disadvantage and detriment of petitioners. In the Interest of Justice; are Pro Se litiganth' rights in the law for self-representation in US courts just for window dressing while attorneys get a free pass in instances when the opponents are Pro Se?

Counsel of record

For petitioner
Afoluso Adesanya

For respondent
Robert E. Bartkus
McCusker, Anselmi, Rosen & Carvelli, P.C.

Case

Conference history
Distributed for 1 conference

Proceedings

  1. Apr 15 2019
    Petition DENIED.
  2. Mar 27 2019
    DISTRIBUTED for Conference of 4/12/2019.
  3. Mar 15 2019
    Waiver of right of respondent Novartis Pharmaceuticals Corp. to respond filed.
  4. Mar 08 2019
    Letter of March 6, 2019 from counsel for respondent received.
  5. Feb 12 2018
    Petition for a writ of certiorari filed. (Response due March 25, 2019)